Lakshmi Rao
Interventional Cardiology · Royal Oak, MINPI 1336707439
Payments from drug & device makers
Across 225 payments — averaging $116.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$15K
- Inari Medical, Inc.$2K
- Kestra Medical Technology Services, Inc.$2K
- Abiomed$2K
- Boston Scientific$759
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$578
- plus $4K from 29 others
What the payments were for
- Grants$11,14143%
- Travel & lodging$3,25712%
- Food & beverage$10,87842%
- Education$9194%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 39 | $15,364 |
| Inari Medical, Inc. | 25 | $2,074 |
| Kestra Medical Technology Services, Inc. | 42 | $1,742 |
| Abiomed | 24 | $1,694 |
| Boston Scientific | 12 | $759 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 18 | $578 |
| E.r. Squibb & Sons, L.L.C. | 11 | $430 |
| Cvrx, Inc. | 3 | $403 |
| Cardiovascular Systems Inc. | 1 | $360 |
| Philips North America LLC | 3 | $289 |
| Penumbra, Inc. | 2 | $283 |
| Angiodynamics, Inc. | 2 | $263 |
| Bard Peripheral Vascular, Inc. | 1 | $243 |
| Medtronic | 6 | $237 |
| Stryker | 6 | $210 |
| Edwards Lifesciences | 2 | $181 |
| Cardiva Medical, Inc. | 3 | $167 |
| Medical Device Business Services, Inc. | 1 | $137 |
| Vifor Pharma, Inc. | 1 | $116 |
| Shockwave Medical, Inc | 2 | $101 |
| Pfizer | 4 | $83 |
| Amgen | 1 | $74 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $67 |
| W. L. Gore & Associates, Inc. | 1 | $60 |
| Cordis US CORP. | 2 | $38 |
| Actelion Pharmaceuticals US, Inc. | 1 | $32 |
| Spectrawave, Inc | 1 | $31 |
| Johnson & Johnson | 2 | $28 |
| Chiesi USA, Inc. | 1 | $27 |
| Alnylam Pharmaceuticals Inc. | 1 | $27 |
| Impulse Dynamics (USA) Inc. | 1 | $27 |
| Scpharmaceuticals Inc. | 1 | $18 |
| Merck | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $17 |
| AstraZeneca | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FLOWTRIEVER CATHETER, S$1,821
- PROSTAR$1,677
- CT THROMBECTOMY SYSTEM KIT$1,610
- Impella$1,182
- Assure WCD$576
- AVEIR$466
- Diamondback Coronary$360
- Barostim Neo System$312
- WATCHMAN Access System$277
- ENSITE$268
- PRESSUREWIRE$263
- AlphaVac$263
- COROFLOW$219
- OPTIS$190
- ESPRIT$169
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$155
- AVVIGO Guidance System$149
- Indigo System$142
- Smart Coil$141
- Ranger$131
How this compares
$26,194 in reported general payments places this provider in the 65th percentile of 187 interventional cardiology providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 22 | $18,638 |
| EntrestoSacubitril/Valsartan | 13 | $15,939 |
| JardianceEmpagliflozin | 12 | $10,489 |
| BrilintaTicagrelor | 11 | $4,619 |
| Atorvastatin Calcium | 56 | $564 |
| ClopidogrelClopidogrel Bisulfate | 26 | $427 |
| Metoprolol Succinate | 28 | $410 |
| Rosuvastatin Calcium | 15 | $347 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 25 | $303 |
| Losartan Potassium | 23 | $201 |
| Carvedilol | 17 | $179 |
| Furosemide | 29 | $144 |
| Lisinopril | 14 | $130 |
| Amlodipine Besylate | 11 | $95 |
| Metoprolol Tartrate | 19 | $70 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $83 | $18,63822 claims |
| AstraZenecaBrilinta | $17 | $4,61911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 187 interventional cardiology providers in Michigan.
Other interventional cardiology in Royal Oak
- Ryan MadderRoyal Oak$239K
- Amir KakiDetroit$2.3M
- William MerhiGrand Rapids$2M
- Shukri DavidSouthfield$1.6M
- Qaiser ShafiqSouthgate$1.3M
- Marcel ZughaibSouthfield$1.2M
- Jason RicciPetoskey$1.1M
- Khaldoon AlaswadDetroit$1.1M
- Paul GrossmanAnn Arbor$1.1M
- Tamam MohamadDetroit$960K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.